Premier Partners

Premier Partners is a Seoul-based investment firm established in 2005 that focuses on venture capital and private equity investments in South Korea. It targets small- to mid-sized companies across sectors such as mobility, healthcare, e-commerce, and digital content, employing an alternative investment approach to support growth throughout the Korean market. The firm serves both individuals and businesses by providing investment services and managing capital for selective investments.

Hosung Ahn

Director

Seungmin Baeg

Principal

Hyun-moo Cho

Director

Joonyoun Cho

Managing Partner

Sung-In Chung

Co-Founder, Co-CEO and Managing Partner

SungIn Chung

Managing Partner / Founder

Jungpyo Hong

Principal

Cheongjo Hwang JD

Principal

Hyeonhwan Jang

Principal

Donghoon Jeon

Principal

Sunjae Jung

Principal

Jinho Kim

Principal

Minbeom Kim

Managing Director

Daniel Kim

Principal

Kyung Kim

Senior Associate

Seong Kim

Managing Partner / CEO

Kim Sung woong

CEO

Tae woong Kwon

Partner and Managing Director

Donghoon Lee

Managing Partner

Lim, Yongkee

Managing Director and CFO

Jason Oh

Principal

David Oh

Partner and Managing Director

Seungmin Roh JD

Principal

BongSoo Shin

Managing Director

Jay Song

CEO

Hayoung Yun

Director

Past deals in Cosmetics

Healing Paper

Series C in 2025
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Hince

Series B in 2021
Hince is a cosmetics brand that specializes in a diverse range of personal care products, including skin, lip, eye, and face care items. The company focuses on developing mood narrative makeup products, which encompass lipsticks, compacts, eye shadows, and lip glosses. Hince emphasizes the use of natural and vegan ingredients in its offerings, catering to consumers who seek environmentally friendly and ethical options in their beauty routines. By providing a variety of high-quality cosmetics, Hince aims to enhance the beauty experience for its customers while promoting a commitment to sustainability.

Healing Paper

Series B in 2020
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

GF Fermentec

Venture Round in 2019
GF Fermentec is a biotechnology company specializing in the production of bioactive biomaterials, specifically designed for use in cosmetic applications. The company focuses on developing core raw materials, such as ceramides, which are essential for skin moisturizing and the improvement of atopic conditions. Utilizing advanced fermentation technology, GF Fermentec supplies cosmetic firms with safe and effective raw materials, contributing to the creation of high-quality skincare products. Through its innovative approach, the company aims to enhance the efficacy and safety of cosmetic formulations.

Healing Paper

Series A in 2019
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Doctorstech

Venture Round in 2019
Doctorstech is a company specializing in the beauty device industry, focusing on innovative products that enhance the skin's natural beauty. Since its founding in March 2000, Doctorstech has prioritized technological advancement and quality in its product offerings. Among its notable products is the FACE DR, a specialized skin care device that has gained recognition for its cutting-edge technology. The company effectively exports its products to various global markets, including the USA, Europe, Japan, China, Southeast Asia, and Russia, achieving considerable acceptance worldwide. Additionally, Doctorstech has launched the UP5, a personal skin care device that quickly became a leading choice in the global skin care market, particularly excelling in Korea and Japan. The company’s commitment to reliability is underscored by its collaboration with experts and extensive clinical trials, reinforcing its prominent position in the specialized skin care sector.

KNOTUS

Venture Round in 2019
Knotus is a company that specializes in the development and wholesale distribution of pharmaceuticals. Its product offerings include a range of medications such as antibiotics, respiratory drugs, cardiovascular drugs, vitamin tablets, and various healthcare products. In addition to its pharmaceutical operations, Knotus also develops and markets cosmetic products, expanding its portfolio to cater to both health and beauty sectors.

Genome

Series B in 2018
Genome & Company, headquartered in Seongnam, South Korea, specializes in researching microbes and probiotics to develop dietary supplements, cosmeceuticals, and novel drugs targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer-related therapies.

KPT

Venture Round in 2017
During its initial stages, Korea Particle Technology (KPT) witnessed dedicated efforts from all employees to establish the company amidst intense competition. Since then, KPT has grown and progressed, shifting its focus beyond profit-making to prioritize building a reputable image and staying updated. Founded in December 2004 with a mission to apply pharmaceutical preparation technology to cosmetics materials through the "Retinol Stabilization Research Project," KPT relocated to the Ochang Science Industrial Complex in September 2007. As a professional materials developer, KPT acknowledges the significant contributions of passionate researchers from client companies in developing new materials with advanced technology, expressing sincere gratitude towards them. In 2009, KPT set its sights on global competition and remains committed to relentless progress. Just like when walking through an open, snow-covered field, KPT urges caution to pave the way for future generations, turning footprints into a path.

BNC Korea

Venture Round in 2011
BNC Korea Co., Ltd. is a South Korean company based in Daegu that specializes in the research, development, production, and sale of biomaterials. Founded in 2007, it focuses on creating products for the beauty and medical markets, including a range of hyaluronic acid fillers and skin boosters designed to temporarily reduce facial wrinkles. Notable products include Cutegel, Cutegel Lidocaine, and various skin treatment solutions such as face mask gels and brightening peeling gels. Additionally, BNC Korea manufactures medical products like Hibarry, which aids in wound care, and GENTA Q, a collagen sponge for wound protection. The company exports its innovative offerings to 45 countries, demonstrating its commitment to enhancing both aesthetic and therapeutic applications in the field of biomaterials.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.